The flare of rheumatic disease after SARS-CoV-2 vaccination: a review

Y Xie, Y Liu, Y Liu - Frontiers in Immunology, 2022 - frontiersin.org
As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …

Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis

KT Tang, BC Hsu, DY Chen - Biomedicines, 2022 - mdpi.com
Background: Vaccination is one of the most important measures worldwide to halt the
spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of …

Bullous pemphigoid associated with COVID-19 vaccines: an Italian multicentre study

CA Maronese, M Caproni, C Moltrasio… - Frontiers in …, 2022 - frontiersin.org
Bullous pemphigoid (BP) is an autoimmune bullous disease caused by circulating
autoantibodies toward the hemidesmosomal antigens BP180 and BP230. Cases of BP have …

Association between vaccination with the BNT162b2 mRNA coronavirus disease 2019 vaccine and noninfectious uveitis: a population-based study

O Tomkins-Netzer, S Sar, O Barnett-Griness… - Ophthalmology, 2022 - Elsevier
Purpose To assess the association between BNT162b2 mRNA coronavirus disease 2019
(COVID-19) vaccine and the risk of active noninfectious uveitis (NIU). Design Retrospective …

Antibody responses after SARS-CoV-2 vaccination in patients with liver diseases

AD Bakasis, K Bitzogli, D Mouziouras, A Pouliakis… - Viruses, 2022 - mdpi.com
The novel mRNA-based vaccines against SARS-CoV-2 display encouraging safety and
efficacy profiles. However, there is a paucity of data regarding their immunogenicity and …

COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study

P Sen, N Ravichandran, A Nune, JB Lilleker… - …, 2023 - academic.oup.com
Objectives COVID-19 vaccines have been proven to be safe in the healthy population.
However, gaps remain in the evidence of their safety in patients with systemic autoimmune …

Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis

D Nemeth, H Vago, L Tothfalusi, Z Ulakcsai… - Frontiers in …, 2022 - frontiersin.org
Background To investigate the factors that have significant impact on the Severe Acute
Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection and vaccination induced …

Immunity after COVID-19 recovery and vaccination: similarities and differences

D Kamińska, D Dęborska-Materkowska… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is associated with a robust immune response. The …

Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study

E Conticini, M d'Alessandro, S Grazzini… - Internal and Emergency …, 2022 - Springer
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination plays a crucial
role as pivotal strategy to curb the coronavirus disease-19 (COVID-19) pandemic. The …

Molecular mimicry and HLA polymorphisms may drive autoimmunity in recipients of the BNT-162b2 mRNA vaccine: a computational analysis

R Talotta - Microorganisms, 2023 - mdpi.com
Background: After the start of the worldwide COVID-19 vaccination campaign, there were
increased reports of autoimmune diseases occurring de novo after vaccination. This in silico …